发明名称 SOLID ORAL DOSAGE FORM CONTAINING AN ENHANCER
摘要 The invention relates to a pharmaceutical composition and oral dosage forms comprising a DAC inhibitor in combination with an enhancer to promote absorption of the DAC inhibitor at the GIT cell lining. The enhancer can be a medium chain fatty acid or derivative thereof having a carbon chain length of from 6 to 20 carbon atoms. In certain embodiments, the solid oral dosage form is a controlled release dosage form such as a delayed release dosage form.
申请公布号 WO2007146234(A2) 申请公布日期 2007.12.21
申请号 WO2007US13693 申请日期 2007.06.11
申请人 MERRION RESEARCH II LIMITED;LEONARD, THOMAS, W.;O'TOOLE, EDEL;FEENEY, ORLAGH 发明人 LEONARD, THOMAS, W.;O'TOOLE, EDEL;FEENEY, ORLAGH
分类号 A61K38/17;A61K9/24;A61K31/165;A61K31/19;A61K31/403;A61K38/12 主分类号 A61K38/17
代理机构 代理人
主权项
地址